The Séralini affair : a comprehensive review and analysis by Callan, Josh & Universitat Autònoma de Barcelona. Facultat de Biociències
THE SÉRALINI AFFAIR 
A comprehensive review and analysis, by Josh Callan 
2000 
• NK603 is deregulated after the USDA issues a “finding of no significant impact”.  
2001 
• Monsanto starts commercializing the NK603 trait as “Roundup Ready 2”. 
2004 
• Monsanto publishes the results of a 90 day long feeding trial on rats led by Bruce G. 
Hammond. 
Sept. 
2012 
• The journal “Food and Chemical Toxicology” publishes the paper “Long term toxicity of a Roundup 
herbicide and a Roundup-tolerant genetically modified maize”, written by a team of scientists led by Éric 
Séralini. 
October 
2012 
• The first criticisms from peers and scientific journalists begin to appear. 
Novembe
r 2012 
• The EFSA or European Food Safety Agency publishes its preliminary observations on the French 
scientist’s article, admitting that the “scientific quality of the study is not sufficient”. 
Decembe
r 2012 
• Two manifestos come out supporting Séralini and his experiment. 
March 
2013 
• The journal “Food and Chemical Toxicology” publishes a letter to its editor written by the president of 
the French Society of Toxicologic Pathology Elio Barale-Thomas, pointing out critical mistakes in the 
methodology of the experiment and conflicts of interest by Séralini. 
Novembe
r 2013 
• Wallace Hayes, editor of the journal, asks Séralini to withdraw “motu proprio” his 
article. Séralini refuses to do so, and the article is retracted. 
Chronology Introduction 
• In November of 2012, a paper titled “Long term toxicity of a Roundup herbicide and a Roundup-
tolerant genetically modified maize” was published in the prestigious Food and Chemical 
Toxicology yearly journal. In it, the group led by Gilles-Éric Seralini explained a 2-year long study 
in which Sprague-Dawley rats were fed the genetically modified Monsanto maize crop NK603, as 
well as the herbicide RoundUp. The corn percentages were 0% (for the controls), 11%, 22% and 
33%. A different group was fed the NK603 and RoundUp, administered in their water. Finally, a 
third group was only fed glyphosate (RoundUp).  
• The authors concluded: “The results […] demonstrate that […] glyphosate herbicide formulations, 
at concentrations well below officially set safety limits, induce severe hormone-dependent 
mammary, hepatic and kidney disturbances. Similarly, disruption of biosynthetic pathways that 
may result from overexpression of the EPSPS transgene in the GM NK603 maize can give rise to 
comparable pathologies.”  
• These conclusions were heavily criticized, as was the protocol followed during said experiment. 
Scientists claimed that the conclusions were impossible to justify. Peers also criticized the fact 
that a book and a movie were released simultaneously with the paper and the fact that those 
who attended the press conference had to sign a confidentiality agreement. 
• After an exhaustive investigation from the EFSA concluded that the paper should be retracted, it 
was so on November of 2013. 
Why is the experiment flawed? 
Academic Capitalism  
Flaw Explanation 
Strain of rats used is prone to 
developing tumors 
The authors fail to mention that this strain has a 45-80% tumor incidence in the 
absence of exogenous factors. If tumors appear before 90 days, the tested 
compund may be dangerous. It was not the case. 
Number of rats used is too 
small 
 
With only  10 rats per sex and group, the study has no statistical weight.  For 
instance, EPA recommends using 50 rats per sex and group and testing multiple 
species in a carcinogenicity study. 
 
Unethical treatment of 
animals and inhuman use of 
animals for propagandizing 
The photographs in the paper show suffering animals that should have been 
euthanized long before reaching the state they are in.  
 
Also, the fact that no whole body  photographs of the control animals are 
shown is a clear misuse of data to present a biased interpretation. 
Misinterpretation of data If the two male groups fed on GM maize are combined, the incidence of early 
mortality (7/30) is actually lower than that of the control group. 
 
References are cited to support the noxious effect of Roundup, but these data 
were obtained using isolated human hepatocytes, some originating from 
tumors. The scientific evidence offered by these models is limited by the 
artificial nature of assays using single cells under non-physiological conditions. 
Indeed, many compounds that affect such cells have no effect on whole 
organisms. 
 
Failure to measure the water 
consumption  
This makes it impossible to calculate the real exposure to glyphosate from the 
concentrations in the drinking water. 
Unsubstantiated claims For example, the authors attribute the potential effects of GM maize and 
Roundup to endocrine disruption and/or oxidative stress, without any empirical 
evidence. They also state that GM maize and Roundup can induce necrotic 
and/or apoptotic changes, but they do not show any evidence to support these 
statements. 
Other  Inadequate statistical analysis of survival and tumor incidence data (e.g. there is 
no analysis of time to tumor formation). 
 
Data presentation deficiencies (e.g. histopathology incidence/severity data not 
Presented). 
 
Low quality and erroneous histopathology analysis (grouping of dissimilar tumor 
types). 
This expression defines the bilateral dependence between research departments in 
universities and the private industry: the second provides funding for the carrying 
out of studies in universities. The first, in return, produce results that are favorable 
for the company or companies that financed the experiment in the first place.  
  
This phenomenon may also be behind the publication of Séralini’s study, since there 
was more than one company that benefited from it, such as Carrefour and Auchan, 
in addition to other organizations and individuals.  
 
Monsanto’s power structure has close ties with some of the most influential 
organisms on public health. Not only in the U.S., but also in European organisms. 
There are several people who are working or have worked for Monsanto that are or 
were also occupying at the same time a highly influential job on political parties, 
regulatory bodies or administrative entities. So, for example, William Conlon and 
Sam Skinner are members of Monsanto’s legal team, but also work for the 
Department of Justice. Michael Kantor is in Monsanto’s board of directors, 
representing it at times as a lawyer, but also occupies a position in the Secretary of 
Commmerce. Michael A. Friedman is the senior vice president for clinical affairs at 
G.D. Searle & CO (currently merged with Monsanto) and is an acting commissioner 
on the FDA. These are just a few of the examples of the people who work both at 
Monsanto and at an organization closely linked to the development of its practices, 
at a political, regulatory or advisory level. This could not only help Monsanto 
achieve faster approval for products that are sought to be introduced in the market, 
but also perhaps lower the safety standards for their health goods, potentially 
decreasing the economic cost of their development and speeding its income. 
 
As a conclusion, more long term studies are required in order to properly evaluate 
and assess the safety of GMOs. A different, perhaps more independent approach 
is necessary than the one taken in regular risk assessment tests, since these could 
still be more exhaustive. Academic capitalism must be fought, probably with 
publicly and not privately funded experiments, to promote more and better 
communication to the general public and lack of bias. 
